BC COVIDIMMUNOLOGY
Saved by @shah82

DELTA variant. To discuss this, let's actually start with discussing the spike protein of the virus. Remember, the spike protein of the virus is how the virus binds to our host cell. The spike protein is the protein that is encoded by the mRNA & adenovirus-DNA vaccines (J&J)

 The vaccine gives you genetic material that enables YOU to make that spike protein and then you raise an immune response against it (of course natural infection makes you raise an immune response against virus). Genetic material goes away & you have immune response. J&J just one
step "upstream" from mRNA vaccines so gives you DNA which you MAKE into mRNA and then you make spike protein. mRNA vax allows you to make protein directly. Not that different though J&J vax takes longer to give full immunity (phase II trial, up to 60 days)
https://t.co/RHLOe6leWZ
Okay, now consider this fact: you make at LEAST 87 T cells that line up across the spike protein to combat the virus from a vaccine (will explain 87 in bit). And likely many more. T cell measurement takes fancy machines, show you the breadth of the T cell response.
So, this paper is by our CA colleagues @settelab shows you make T cells against 1400 little bits of the virus and postulates 100 or more across the spike protein (enriched for spike protein T cells). And the paper from the AztraZeneca trial in S. Africa
https://t.co/vUG15U8VnT
shows us that 87 T cells line up across the spike protein to fight the virus when you give the vaccine. So, even with the beta variant (used to be called B.1.351), 75 of those T cells still fight that spike protein (the mutations only knock out 13).
https://t.co/GpFJSyDMvQ
So, it will be very difficult to ever knock out your T cell response with mutations along the spike protein. Okay what about the DELTA variant? 12-13 mutations across spike protein so the T cell response you get from vaccines will still cover it. Ok, so
https://t.co/XQ1fGBEAXQ
what do our antibodies do versus T cells? T cells help protect us against severe disease as shown in this article so this is why our T cells from vaccines & natural infection will protect us against hospitalization/death from COVID. In fact, this is why
https://t.co/LlhJntURL8
data from Public Health England yesterday June 14 showed us 2 doses of the vaccine protects you against hospitalization from the delta virus - both the mRNA vaccines and the AztraZeneca vaccine (which is like J&J vax), but 2 doses better for this variant
https://t.co/mZZhi5LtiA
Okay what about antibodies? Since antiboies cluster in the nose (both IgA and IgG antibodies), you want your antibodies high in your nose to not even get mild infection in your nose (like loss of smell, runny nose). The mRNA vaccines do produce Abs
https://t.co/xKeiwTcjxY
to neutralize that delta variant but you really want TWO doses to produce adequate levels. Moreover, after natural infection with COVID, you have those "in breadth" T cell responses that cross the spike protein but you may need an antibody "boost" in your nose to not get mild
infection from the delta variant, which is why giving 1 dose of the mRNA vaccines after natural infection may be indicated (indeed, so many studies now show us that antibody response after 1 dose of mRNA vax boosts antibodies after natural infection more than 2 doses when didn't
have #covid19 before. If variant transmits more readily like delta variant, will go around and infect those unvax'd or cause mild nasal symptoms in those who have had natural infection if nasal antibodies go down. But rare to cause severe disease in those vax'd /natural infection
Children less likely to get infection even in nose after exposure (3-fold less than adults), less likely to get severe disease from any variant or original. Virologists don't think strain more virulent (e.g. cause more severe disease). NOT vax resistant
https://t.co/uZP0BOHy4I
And, yes, J&J vaccine gives great antibody and T cell responses across spike protein so will protect you against this variant as well (look at that T cell response)
https://t.co/VxdLQzE9dt
The reason we want the 2 doses of Pfizer to protect against delta variant is here (don't have data on J&J in "real world" but above tweet shows the T cell immunity)- 1 dose not as effective for delta (33-50%) so need 2 doses
https://t.co/2dRIgYq3Le
Great delta variant-relieving study even in face of high circulating virus with this variant in India. Study in 31,621 health care workers in India Jan-March. Even after 1 dose (some had 1 dose, some fully vax with 2 doses) >95% protected! 4.28% infected
https://t.co/dno3fTziqx
post-vax & most non-serious (no deaths). Most got AztraZeneca & this is important: after 1 dose, 5.14% re-infected, after 2 dose 4.09% re-infected (again most mild) so that is helpful to know how protective 1 dose is in the face of MOST of virus being delta variant & circulating
at high levels & this is healthcare workers who had a lot of exposure! Remember, the risk of us extrapolating from one study (UK) without looking at other studies (India) can lead to a lot of concern. Delta ore transmissible; likely not more virulent; not vaccine resistant
**Heard back from colleagues in UK. 33% efficacy after dose 1 for delta averaged over two weeks following 1st dose while immune response increasing (continue precautions 1st 2 weeks. Immunity to dose 1 against delta was 80% after 1st 2 weeks. Consistent with India data above.
This tweet thread from @EricTopol may be helpful to add to my delta variant thread. I am intent on & will continue to explain the immunology behind these findings about the variants- maybe more transmissible but not more virulent nor immunity resistant.
https://t.co/LH81ioFZFB
Try to explain delta variant verbally here - reason important to not "parrot discuss" delta is 1) UK gave 1st dose 1st strategy; should be careful 2 weeks after 1st dose with 33% but after that, 80% effectiveness against delta, consistent with India
https://t.co/juK9X8puHf
data which is largest dataset on this; 2) delta being used as reason to keep parents scared by some papers (@DLeonhardt at @NYT notable exception) which may not allow parents to think about myocarditis risk of 2 doses in young males & await @ACIP recs; 3) delta pushed by some to
keep schools restricted instead of following metrics-based approach where restrictions for kids cease when @CDC metrics of low hospitalizations (<5/100K in population reached); 4) doom based messaging so common but can paradoxically decrease vax uptake
https://t.co/xiDMjy61Lc
Helpful article by @DLeonhardt at @NYT on delta variant in children. Agree with @JenniferNuzzo that we haven't seen data that this variant more dangerous for children.
https://t.co/bds5xsQDcl
See scientists trying to "motivate vaccines" by discussing delta variant. Like alpha, not shown to be more virulent; more transmissible or will become dominant strain, nor vax resistant. natural immunity/high vax rate in vulnerable great- please read this:
https://t.co/APXkEUNO1P
Dr. Fauci at White House today said "eliminate" COVID but had indicated previously goal in US is "control" which is achievable goal (like measles) which allows life to stop disruption. By the way, he said elimination in this article for word "eradication"
https://t.co/iD3zBnD0GG
Good definitions!
Control: Reduce # of people infected & those who become sick/die from disease in LOCAL settings
Elimination: Stopping transmission of disease in specific area or country, not worldwide
Eradication: Eliminating world (only smallpox)
https://t.co/MTJZ8eBKFy
In summary, seeing some of the ? below- no evidence that delta variant more virulent (that would result in an increased hospitalization/case ratio and that ratio is actually going down because younger unvax'd getting it); no evidence delta evades vax; no need for mRNA after J&J
One way to explain: If higher virulence, then will see more hospitalizations per case - so say 1 out of every xx cases get hospitalized, do we now see 2 or 3 of every xx cases get hospitalized with new variant? Hospitalization/case ratio (H/C) increased?
https://t.co/2UijxHkaVr
We went through this with alpha- lot of conflicting data since as cases go up, admissions go up but doesn't mean it causes more severity. Think cleanest way to look at this is H/c ratio; we did that analysis with B117 & didn't see (see thread above & here)
https://t.co/HfZl8IAVXq
At this point, it is important to get vaccinated, I encourage it. Delta or not, vaccines are here & young (who are less at risk & busy) should get. Tomorrow, we will hear ACIP recs on younger males for side effect. Think fear variant will evade vax disputed by T cell immunity
Remember when looking at H/c ratio, depends on if you are capturing all cases (decreased testing with vax going up, cases or denominator will be lower). So much confounding in epi. Best to go back to principles of Virology on variants, author of TEXTBOOK
https://t.co/XR0wypOU5Q
BREAKING NEWS ON DELTA VARIANT (except not really, preprint was posted PHE on June 14): Vaccine effectiveness against hospitalization with delta was similar to that seen with alpha - 94% after 1st dose, 96% after 2nd dose Pfizer. 71% after 1st dose with AZ; 92% after 2 doses
Preprint here. Just like in India data. So, let's do this. Decide on young males 2nd dose with safety in mind as effectiveness of even 1 dose of Pfizer very high. Stay calm with variants. T cell immunity can't evade. Message confidence in vax to increase uptake
Preprint here from Public Health England: https://t.co/qUwl2cMObV

You May Also Like

Chris Herd
Chris Herd
@chris_herd
The 2020s will be known as the Remote Work decade

A few predictions of what is likely to emerge

[ a thread ] 💻🏠🌍

🏦Third Space: Office and Working from Home will be joined by somewhere close by that a number of people will use

Supermarkets or local bank branches should emerge as a convenient ubiquitous location option – if they are smart

⏰Asynchronous Work: Offices are instantaneous gratification distraction factories where synchronous work makes it impossible to get stuff done

Tools that enable asynchronous work are the most important thing globally remote teams need. A lot of startups will try to tackle this

⚽️Hobbie Renaissance: Remote working will lead to a rise in people participating in hobbies and activities which link them to people in their local community

This will lead to deeper, more meaningful relationships which overcome societal issues of loneliness and issolation

🚜Rural Living: World-class people will move to smaller cities, have a lower cost of living & higher quality of life

These regions must innovate quickly to attract that wealth. Better schools, faster internet connections are a must
REMOTE WORK
Vibhu Vashisth
Vibhu Vashisth
@VIBHU_Tweet
RANI NAIKI DEVI AND THE BATTLE OF KASAHRADA

Mohammad Ghori, the young Ghurid Prince conquered Ghaznavids in Afghanistan in the year 1173 CE. He conducted some successful raids into the Indian territory, which even Mahmud Ghazni & the Persians couldn't do.


First&foremost,Ghori invaded states of Multan &Uch in India.After this he turned to southern states of Gujarat &Rajputana.Everybody knows this about Ghori,but what most pple r unaware of is the defeat he suffered at hands of Chalukyan Queen Naiki Devi in 1178 Battle of Kasahrada.


When he marched southwards, his first target was the prosperous fortified town of Anhilwara Patan.
It was the capital of Chalukyas(also known as Solankis of Gujarat) which was established by Vanraj of Chapotkata Dynasty in 8th century.


American historian Tertius Chandler states that it was the 10th largest city in the world at that time. The history of Chalukyas has been written by many historians, but the valour of the Great Queen Naiki Devi remains unsung.


Born to the Kadamba King Paramardin of Goa,Naiki Devi was well trained in sword fighting, horse riding, strategy & every other subject of Statesmanship. She was married to King Ajaypala of Gujarat who sat on throne in 1171CE. Unfortunately,the King died within 4 yrs of his rule.
ALL
Advertisement
Corey Gwin
Corey Gwin
@corey_gwin
Great thread full of potential https://t.co/jA8h08M48z ideas! 💡

📸 Social disposable camera app

Create a digital "roll" with friends. Take pictures from the roll. You can't see them until: the roll is used up, a time limit expires, or you get to a specific location.

🎙 Asynch interview platform

Send a guest a video or audio clip asking a question. Guest replies when able with same medium. Repeat. When done, share produced video/podcast.

✅ 24 Hour Startup Checklist/Overlay

A web app to track the progress of your project: ideation, naming, shipping code, launching.

Page can also be a dynamic browser overlay for live streaming.

Have tools for polls, surveys, sharing, launching to various outlets, etc.

👩‍⚖️ Healthcare "Lawyers"

If health insurance screws you over, no one has your back but you. Instead, can pay a small monthly fee to a service to take care of BS like this for you should issues arise.
TECH
Aditya Todmal
Aditya Todmal
@AdityaTodmal
A Thread on the Boss himself @Mitesh_Engr

Mitesh Sir's Positional Option Selling 101:

• How to find direction
• Which options to sell
• How to deploy capital
• Exit criteria
• What ROI he targets weekly
• What % risk he takes

Done with the help of @niki_poojary


How @Mitesh_Engr Sir finds the direction?

• Daily charts S/R
• 75 min charts S/R
• Intraday trend
• Always play directional
• Never trades in strategies


Which options to sell in weekly expiry according to @Mitesh_Engr?

• Weekly candle High/Low
• Sell 1% away options from those
• Exit when levels breached


Position Sizing by @Mitesh_Engr Sir.

How to deploy your capital?

• First sell 20%
• Pyramid the next day
• When to exit
• What to do when view goes wrong
• What to do with idle capital


Some important tweets of @Mitesh_Engr Sir

• What Data to look at
• ROI for safe players per month
• Max risk per day
• Gather knowledge and play directional
• Never play strategies
OPTIONS LEARNING , ALL , MPLEARNINGS
Vedic Gyaan
Vedic Gyaan
@vedicgyaanindia
The chorus of this song uses the shlokas taken from Sundarkand of Ramayana.

It is a series of Sanskrit shlokas recited by Jambavant to Hanuman to remind Him of his true potential.

1. धीवर प्रसार शौर्य भरा: The brave persevering one, your bravery is taking you forward.


2. उतसारा स्थिरा घम्भीरा: The one who is leaping higher and higher, who is firm and stable and seriously determined.

3. ुग्रामा असामा शौर्या भावा: He is strong, and without an equal in the ability/mentality to fight

4. रौद्रमा नवा भीतिर्मा: His anger will cause new fears in his foes.

5.विजिटरीपुरु धीरधारा, कलोथरा शिखरा कठोरा: This is a complex expression seen only in Indic language poetry. The poet is stating that Shivudu is experiencing the intensity of climbing a tough peak, and likening

it to the feeling in a hard battle, when you see your enemy defeated, and blood flowing like a rivulet. This is classical Veera rasa.

6.कुलकु थारथिलीथा गम्भीरा, जाया विराट वीरा: His rough body itself is like a sharp weapon (because he is determined to win). Hail this complete

hero of the world.

7.विलयगागनथाला भिकारा, गरज्जद्धरा गारा: The hero is destructive in the air/sky as well (because he can leap at an enemy from a great height). He can defeat the enemy (simply) with his fearsome roar of war.
VEDICGYAN